Bradley E Aouizerat1, Anand Dhruva2, Steven M Paul3, Bruce A Cooper3, Kord M Kober3, Christine Miaskowski4. 1. School of Nursing, University of California, San Francisco, California, USA; Institute for Human Genetics, University of California, San Francisco, California, USA. 2. School of Medicine, University of California, San Francisco, California, USA. 3. School of Nursing, University of California, San Francisco, California, USA. 4. School of Nursing, University of California, San Francisco, California, USA. Electronic address: chris.miaskowski@ucsf.edu.
Abstract
CONTEXT: Little is known about energy levels in oncology patients and their family caregivers. OBJECTIVES: This study sought to identify latent classes of participants, based on self-reported energy levels and evaluate for differences in phenotypic and genotypic characteristics between these classes. METHODS: Energy subscale scores from the Lee Fatigue Scale were used to determine latent class membership. Morning and evening energy scores were obtained just before, during, and for four months after the completion of radiation therapy. Genetic associations were evaluated for 15 proinflammatory and anti-inflammatory cytokine genes. RESULTS: Two latent classes with distinct morning energy trajectories were identified. Participants who were younger, female, not married/partnered, black, and had more comorbidities, and a lower functional status were more likely to be in the low morning energy class. Two polymorphisms (IL2 rs1479923 and NFKB1 rs4648110) were associated with morning energy latent class membership. Two latent classes with distinct evening energy trajectories were identified. Participants who were younger and male and who had more comorbidities, decreased body weight, and a lower functional status were more likely to be in the moderate evening energy class. Five different polymorphisms (IL1R2 rs4141134, IL6 rs4719714, IL17A rs8193036, NFKB2 rs1056890, and TNFA rs1800683) were associated with evening energy latent class membership. CONCLUSION: This study provides preliminary evidence that decrements in morning and evening energy are associated with different phenotypic risk factors and cytokine gene variations.
CONTEXT: Little is known about energy levels in oncology patients and their family caregivers. OBJECTIVES: This study sought to identify latent classes of participants, based on self-reported energy levels and evaluate for differences in phenotypic and genotypic characteristics between these classes. METHODS: Energy subscale scores from the Lee Fatigue Scale were used to determine latent class membership. Morning and evening energy scores were obtained just before, during, and for four months after the completion of radiation therapy. Genetic associations were evaluated for 15 proinflammatory and anti-inflammatory cytokine genes. RESULTS: Two latent classes with distinct morning energy trajectories were identified. Participants who were younger, female, not married/partnered, black, and had more comorbidities, and a lower functional status were more likely to be in the low morning energy class. Two polymorphisms (IL2rs1479923 and NFKB1rs4648110) were associated with morning energy latent class membership. Two latent classes with distinct evening energy trajectories were identified. Participants who were younger and male and who had more comorbidities, decreased body weight, and a lower functional status were more likely to be in the moderate evening energy class. Five different polymorphisms (IL1R2rs4141134, IL6rs4719714, IL17Ars8193036, NFKB2rs1056890, and TNFArs1800683) were associated with evening energy latent class membership. CONCLUSION: This study provides preliminary evidence that decrements in morning and evening energy are associated with different phenotypic risk factors and cytokine gene variations.
Authors: Joanne E Mortimer; Andrea M Barsevick; Charles L Bennett; Ann M Berger; Charles Cleeland; Shannon R DeVader; Carmen Escalante; Jeffrey Gilreath; Arti Hurria; Tito R Mendoza; Hope S Rugo Journal: J Natl Compr Canc Netw Date: 2010-12 Impact factor: 11.908
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Christine Miaskowski; Bruce A Cooper; Steven M Paul; Marylin Dodd; Kathryn Lee; Bradley E Aouizerat; Claudia West; Maria Cho; Alice Bank Journal: Oncol Nurs Forum Date: 2006-09-01 Impact factor: 2.172
Authors: R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton Journal: Eur J Cancer Date: 1994 Impact factor: 9.162
Authors: Hamza Abid; Kord M Kober; Betty Smoot; Steven M Paul; Marilyn Hammer; Jon D Levine; Kathryn Lee; Fay Wright; Bruce A Cooper; Yvette P Conley; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2017-01-04 Impact factor: 3.612
Authors: Kimberly Alexander; Yvette P Conley; Jon D Levine; Bruce A Cooper; Steven M Paul; Judy Mastick; Claudia West; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2017-09-23 Impact factor: 3.612
Authors: Fay Wright; Laura B Dunn; Steven M Paul; Yvette P Conley; Jon D Levine; Marilyn J Hammer; Bruce A Cooper; Christine Miaskowski; Kord M Kober Journal: Cancer Nurs Date: 2019 Sep/Oct Impact factor: 2.592
Authors: Komal Singh; Steven M Paul; Kord M Kober; Yvette P Conley; Fay Wright; Jon D Levine; Paule V Joseph; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2019-11-02 Impact factor: 3.612
Authors: Christine Miaskowski; Yvette P Conley; Judy Mastick; Steven M Paul; Bruce A Cooper; Jon D Levine; Mitchell Knisely; Kord M Kober Journal: J Pain Symptom Manage Date: 2017-08-08 Impact factor: 3.612
Authors: Kord M Kober; Betty Smoot; Steven M Paul; Bruce A Cooper; Jon D Levine; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2016-09-21 Impact factor: 3.612
Authors: Melisa L Wong; Steven M Paul; Judy Mastick; Christine Ritchie; Michael A Steinman; Louise C Walter; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2018-08-23 Impact factor: 3.612
Authors: Lindsey E Bischel; Christine Ritchie; Kord M Kober; Steven M Paul; Bruce A Cooper; Lee-May Chen; Jon D Levine; Marilyn Hammer; Fay Wright; Christine Miaskowski Journal: Eur J Oncol Nurs Date: 2016-07-15 Impact factor: 2.398